Acridone derivatives are selective inhibitors of HIV-1 replication in chronically infected cells
Authors:
- Masanori BabaMBMasanori Baba
- 1 October 1999
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 43 (3) , 189-199
Abstract
No abstract availableKeywords
Funding Information
- Japan Health Sciences Foundation
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 38 references indexed in Scilit:
- Potent Inhibition of HIV Type 1 Replication by an Antiinflammatory Alkaloid, Cepharanthine, in Chronically Infected Monocytic CellsAIDS Research and Human Retroviruses, 1998
- Cellular factors as alternative targets for inhibition of HIV-11This review is based on the presentation originally made at the Ninth International Conference on Antiviral Research in Urabandai, Fukushima, Japan, May 19–24, 1996.1Antiviral Research, 1997
- Inhibition of HIV Activation in Latently Infected Cells by Flavonoid CompoundsAIDS Research and Human Retroviruses, 1996
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- Novel indolocarbazole protein kinase C inhibitors prevent reactivation of HIV-1 in latently infected cellsAntiviral Research, 1993
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.Journal of Experimental Medicine, 1993
- N-Acetylcysteine Inhibits Latent HIV Expression in Chronically Infected CellsAIDS Research and Human Retroviruses, 1991
- Anti-herpesvirus activity of citrusinine-I, a new acridone alkaloid, and related compoundsAntiviral Research, 1989
- Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compoundsJournal of Virological Methods, 1988